Connection

A Mebazaa to HIV Protease Inhibitors

Back to Details
This is a "connection" page, showing publications A Mebazaa has written about HIV Protease Inhibitors.
A Mebazaa
Connection Strength
0.417
HIV Protease Inhibitors
  1. Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor. J Antimicrob Chemother. 2018 09 01; 73(9):2480-2484.
    View in: PubMed
    Score: 0.281
  2. Efficacy and safety of boosted darunavir-based antiretroviral therapy in HIV-1-positive patients: results from a meta-analysis of clinical trials. Sci Rep. 2018 03 27; 8(1):5288.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.